Increasing CGM Use Among Patients With T2D
Increasing Use of Continuous Glucose Monitors Among Patients With Type 2 Diabetes
San Diego State University
318 participants
Nov 4, 2024
INTERVENTIONAL
Conditions
Summary
Study Overview: This interventional study aims to assess whether training healthcare professionals (HCPs) increases the number of continuous glucose monitor (CGM) prescriptions for patients with Type 2 Diabetes in a Federally Qualified Health Center serving a predominantly Hispanic/Latino population. Research Questions: Does HCP training enhance CGM prescription rates in a primary care setting? Does receiving a CGM prescription lead to improved Type 2 Diabetes control, as measured by Hemoglobin A1c levels? What barriers do patients face when prescribed and using CGMs? Given the significant impact of CGMs on diabetes management, this project seeks to improve CGM utilization among eligible patients through a focused intervention for HCPs and evaluate diabetes outcomes for those who do and do not receive a CGM. Methodology: HCPs and staff from three clinics within the same healthcare system will undergo a brief, in-person training on current clinical guidelines and insurance eligibility for CGMs. A booster session will follow about one month later to reinforce learning and address any prescribing challenges. Training efficacy will be evaluated by comparing CGM prescription rates before and after training using electronic health records. HCPs will complete pre- and post-training surveys to assess changes in knowledge, beliefs, and prescribing practices related to CGMs. Additionally, a small subset of prescribers will participate in interviews about their experiences with CGM prescriptions four months post-training. Patient Recruitment and Surveys: Patients with Type 2 Diabetes will be recruited for surveys at baseline, and at 3 and 6 months. These surveys will gather information on their diabetes management experience, levels of diabetes distress, and whether CGM discussions occurred with their primary care provider. Participants who received CGM prescriptions will share their experiences and any barriers encountered. A subset will also be invited for interviews to further explore their CGM experiences. Conclusion: This study seeks to fill a crucial gap in understanding how HCP training influences CGM prescription rates and the associated diabetes management outcomes, ultimately aiming to enhance diabetes care for a vulnerable population.
Eligibility
Inclusion Criteria8
- Participant Eligibility:
- adults 18 years or older,
- have been diagnosed with T2D at least one year prior to recruitment,
- are a current patient of one of the three participating Innercare Clinics with no -
- plans to discontinue their care at Innercare within the next 6 months,
- can understand and speak in English or Spanish,
- have telephone access,
- do not plan to move out of the area within the next 6 months.
Exclusion Criteria9
- Plans to move out of the area in the next 6 months
- Patients with newly diagnose diabetes mellitus (less than one year), diabetes insipidus, diabetes type 1 or gestational diabetes.
- Provider/Staff Eligibility:
- Inclusion
- years or older,
- able to read and write in English,
- currently employed at one of the participating Innercare clinics (Brawley, El Centro, Calexico),
- currently be treating at least one adult patient for T2D, scheduled to complete the CGM toolkit training. Exclusion
- Personnel without experience providing care to adult patients with T2D in primary care settings.
Interventions
A CGM prescription toolkit was created for prescribing clinicians and staff that includes written guidance on CGM eligibility criteria, instructions for screening patients for eligibility using EHR records and during healthcare visits, recommended provider documentation templates to address all required eligibility criteria for insurance coverage of CGM device and supplies (e.g., Medicare, Medicaid), sample scripts for communicating with patients about the purpose and use of CGM, and patient-level frequently asked questions (FAQs), including free resources available to learn more about CGM benefits, where/how to acquire CGM, and determining out-of-pocket costs. The toolkit will be introduced during a 20 minute initial training session and reinforced during a 10 minute booster training approximately one month after initial training
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06638099